We thank Li et al.1 for their interest in our study and for their thoughtful comments regarding the development of an artificial intelligence (AI)-powered multimodal model for predicting recurrence and survival in head and neck squamous-cell carcinoma.2
ESMO Open published a clinical update in Oncology on 31 Mar 2026.
The item focuses on Response to letter re: “Artificial intelligence-powered real-time multimodal model for predicting recurrence and survival in head and neck cancer: a multicenter, multinational study”.
Review the original article for the full source wording and details.